The aim of this article is to discuss the role of lipid parameters such as APOB/APOA1 in CAVD and the risk factors for CAVD, to develop a predictive model for CAVD, and to evaluate the sensitivity and specificity of this model. The gene discussed is APOB; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.